Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an international business services hub in Warsaw, Poland, as the Company continues to build out a global infrastructure. The Moderna International Business Services (MIBS) Center complements the six commercial legal entities that have already been established across Europe.
The MIBS Center will serve Moderna’s growing international business by providing critical functions, including finance, pharmacovigilance, human resources and digital services. The Center is expected to employ approximately 160 staff when fully operational. Moderna plans to start Center operations in the third quarter of this year.
“We’re delighted to be expanding our footprint in Europe,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Warsaw is a compelling location for this global business services hub given its access to talent, costs of operations, business climate and infrastructure quality.”
The MIBS Center will provide new capabilities and capacity to help meet the growing demand of Moderna’s global business operations. Additionally, it will play a key role in providing business insights while improving, simplifying, and standardizing processes.